LifePoint's saliva test gains broad US patent
This article was originally published in Clinica
LifePoint has been awarded a fundamental US patent for its noninvasive, saliva-based drug testing technology that can provide results comparable to those obtained from a blood sample.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?